Commonwealth Bank of Australia decreased its holdings in shares of Clorox Company (The) (NYSE:CLX) by 5.3% in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 10,710 shares of the company’s stock after selling 602 shares during the period. Commonwealth Bank of Australia’s holdings in Clorox were worth $1,406,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Parkside Financial Bank & Trust grew its holdings in shares of Clorox by 3.8% during the second quarter. Parkside Financial Bank & Trust now owns 796 shares of the company’s stock valued at $107,000 after buying an additional 29 shares during the last quarter. Valley National Advisers Inc. grew its holdings in shares of Clorox by 0.6% during the second quarter. Valley National Advisers Inc. now owns 865 shares of the company’s stock valued at $115,000 after buying an additional 5 shares during the last quarter. Blue Chip Partners Inc. grew its holdings in shares of Clorox by 3.9% during the second quarter. Blue Chip Partners Inc. now owns 941 shares of the company’s stock valued at $125,000 after buying an additional 35 shares during the last quarter. Sun Life Financial INC grew its holdings in shares of Clorox by 10,344.4% during the second quarter. Sun Life Financial INC now owns 940 shares of the company’s stock valued at $125,000 after buying an additional 931 shares during the last quarter. Finally, Acrospire Investment Management LLC purchased a new stake in shares of Clorox during the second quarter valued at approximately $133,000. 73.42% of the stock is owned by institutional investors and hedge funds.

A number of equities research analysts have recently commented on the stock. Jefferies Group reiterated a “hold” rating and set a $137.00 price target (up previously from $136.00) on shares of Clorox in a report on Wednesday, August 9th. Royal Bank Of Canada reiterated a “hold” rating and set a $115.00 price target on shares of Clorox in a report on Sunday, October 8th. BMO Capital Markets reiterated an “outperform” rating on shares of Clorox in a report on Tuesday, September 12th. Consumer Edge upgraded shares of Clorox from a “neutral” rating to an “outperform” rating in a report on Friday, November 10th. Finally, Morgan Stanley cut their price target on shares of Clorox from $138.00 to $128.00 and set an “equal weight” rating on the stock in a report on Thursday, November 2nd. Two analysts have rated the stock with a sell rating, nine have given a hold rating and three have issued a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $128.72.

In related news, SVP Matthew T. Laszlo sold 20,051 shares of the firm’s stock in a transaction that occurred on Wednesday, November 8th. The shares were sold at an average price of $130.46, for a total value of $2,615,853.46. Following the sale, the senior vice president now owns 10,896 shares in the company, valued at $1,421,492.16. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Michael R. Costello sold 10,574 shares of the firm’s stock in a transaction that occurred on Tuesday, November 28th. The stock was sold at an average price of $136.01, for a total transaction of $1,438,169.74. Following the completion of the sale, the senior vice president now owns 34,867 shares in the company, valued at approximately $4,742,260.67. The disclosure for this sale can be found here. Company insiders own 1.00% of the company’s stock.

Shares of Clorox Company (CLX) opened at $142.45 on Tuesday. Clorox Company has a fifty-two week low of $113.01 and a fifty-two week high of $143.18. The company has a debt-to-equity ratio of 3.02, a current ratio of 1.10 and a quick ratio of 0.77. The stock has a market cap of $18,004.99, a P/E ratio of 25.16, a P/E/G ratio of 3.81 and a beta of 0.43.

Clorox (NYSE:CLX) last issued its earnings results on Wednesday, November 1st. The company reported $1.46 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.41 by $0.05. Clorox had a net margin of 11.84% and a return on equity of 161.59%. The company had revenue of $1.50 billion for the quarter, compared to analysts’ expectations of $1.48 billion. During the same quarter last year, the company posted $1.36 earnings per share. The firm’s quarterly revenue was up 4.0% on a year-over-year basis. analysts expect that Clorox Company will post 5.58 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Friday, February 9th. Investors of record on Wednesday, January 24th will be issued a $0.84 dividend. This represents a $3.36 annualized dividend and a yield of 2.36%. The ex-dividend date is Tuesday, January 23rd. Clorox’s dividend payout ratio is currently 61.88%.

WARNING: This story was originally reported by TheOlympiaReport and is owned by of TheOlympiaReport. If you are viewing this story on another website, it was stolen and republished in violation of United States & international copyright and trademark law. The legal version of this story can be read at https://theolympiareport.com/2017/12/05/commonwealth-bank-of-australia-has-1-41-million-holdings-in-clorox-company-the-clx.html.

About Clorox

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with Analyst Ratings Network's FREE daily email newsletter.